Board Appointment

Imaging Biometrics Limited

("IBAI" or the "Company")

Board Appointment

Imaging Biometrics Limited (LSE: IBAI) is pleased to announce the appointment of John Charles Richardson as a Non-Executive Director with effect from 1 March 2026 and will become a member of the remuneration and audit committees.

John is a British Chartered Engineer with over 40 years of experience in technology, operations and strategic management. A graduate of the University of Manchester in Electrical and Electronic Engineering, he spent nearly three decades in engineering management at a major international engineering company, progressing to senior roles spanning corporate engineering strategy, marketing and information security.

Since then, he has held a series of executive and board-level roles across listed and private technology companies in sectors including machine monitoring, life sciences and land surveying. He has a strong record of operational delivery, having achieved ISO 9001 and CE certifications, established international distribution networks across China, the USA and South Korea, and driven significant revenue growth.

Current Directorships                         Previous Directorships in the past five years

ChampagneWebs Limited                     Nanosynth Group plc

Gyrometric Systems Limited                 Geocurve Ltd

John currently does not hold any Ordinary Shares in the Company.

There are no additional matters that would require disclosure under LR 6.4.8R in respect of the appointment of John Richardson.

--ENDS-

For further information, please contact:

About Imaging Biometrics Limited: Imaging Biometrics Limited (LON: IBAI) is the parent company of Imaging Biometrics LLC and Kirkstall Ltd, focused on advancing innovative solutions that support improved decision‑making and outcomes across healthcare and life sciences, spanning quantitative medical imaging and advanced in vitro modelling technologies. Through its subsidiaries, the company delivers products, services, and expertise that help clinicians, researchers, and industry partners work more efficiently and effectively.